Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Human Immunodeficiency Virus (HIV): early-phase trial registry
7 of 19 indexed Human Immunodeficiency Virus (HIV) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 7 currently recruiting · #902 of 28,707 conditions by registered trial count
Human Immunodeficiency Virus (HIV): 19 US clinical trials tracked, 7 recruiting.
Human Immunodeficiency Virus (HIV) is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is AbbVie, running 2 of these trials.
Enrollment posture brief
Registry condition human-immunodeficiency-virus-hiv
OPEN 7 | RECR 37% | LATE 2 | EARLY 7 | RANK #902 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Binge Eating (37% recruiting · 19 trials)
Human Immunodeficiency Virus (HIV) lists 7 open slots (37% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Human Immunodeficiency Virus (HIV) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Human Immunodeficiency Virus (HIV) is recruiting below its size-band peers.
7 of 19 indexed trials (36.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Human Immunodeficiency Virus (HIV) trials is spread across many organizations.
AbbVie accounts for 2 of 19 trials (10.5%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Human Immunodeficiency Virus (HIV) enrolment sits around 124 participants.
Median target enrolment is 124 among the 19 trials that report a genuine target (sentinel values excluded). 8 of those (42.1%) plan for fewer than 100 participants.
-
Human Immunodeficiency Virus (HIV) research is mostly interventional.
17 interventional and 2 observational studies make up this index (89.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Merck Sharp & Dohme
NCT07044297
Persuasive Health Communication Intervention for HIV/HCV
Icahn School of Medicine at Mount Sinai
NCT05968573
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
New York University
NCT06598397
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Wake Forest University Health Sciences
NCT06883097
e-HERO: Ending the HIV Epidemic in Rural Oklahoma
Northern Arizona University
NCT05664802
Project neuroARTEMIS
Wake Forest University Health Sciences
NCT06814275
The Trans-Led Care Study
Illinois Institute of Technology
NCT06880705
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
April M Young
NCT05657106
New Strategies to Assess Anal Cancer Risk In Women
Emory University
NCT02873741
Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis
PATH
NCT02165202
Evaluating Rewards-Based Adherence and Electronic Medication Monitoring in HIV-Positive Adolescents
St. Jude Children's Research Hospital
NCT01849393
Safety, Tolerability, and Immunogenicity of ALFQ in a HIV Vaccine Containing A244 and B.65321 in Healthy Adults
U.S. Army Medical Research and Development Command
NCT05423418
Tesamorelin Effects on Liver Fat and Histology in HIV
Massachusetts General Hospital
NCT02196831
Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)
AbbVie
NCT04554966
Romidepsin Plus 3BNC117 Phase 2a Study
Rockefeller University
NCT02850016
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1
AbbVie
NCT04223804
A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected Children
Janssen Research & Development
NCT05197075
A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)
Merck Sharp & Dohme
NCT06783192
Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission
Johns Hopkins University
NCT01053741
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Human Immunodeficiency Virus (HIV) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Human Immunodeficiency Virus (HIV) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Human Immunodeficiency Virus (HIV) page
19 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 7 Human Immunodeficiency Virus (HIV) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- AbbVie sponsors the most Human Immunodeficiency Virus (HIV) trials on record, review their full trial history before evaluating a specific study. See AbbVie's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Human Immunodeficiency Virus (HIV) condition card totals 19 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.